Asking for Preferences

Which question(s) would you like me to answer?

This is an ENT (Otorhinolaryngology) exam paper. I'll read the medical library skill first, then research all 16 topics in parallel.
Reading File
Now I'll search for all topics in parallel to maximize coverage within my budget:
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Good - there are ENT books. Let me find them:
Finding Sources
Finding Sources
Finding Sources
I've reached my query_library_db limit. I have good contextual knowledge of all these ENT topics. Let me now write comprehensive answers for all 16 questions using my extensive medical knowledge, supplemented by what I've found.Here are comprehensive answers to all 16 questions:

ENT Exam - Complete Answers


LONG ESSAY (10 Marks)


Q1. Surgical Management of CSOM (Chronic Suppurative Otitis Media)

Definition: CSOM is a chronic inflammation of the middle ear and mastoid with persistent discharge through a tympanic membrane perforation for more than 2-3 months.
Types:
  1. Tubotympanic (Safe/Mucosal) type - central perforation, no cholesteatoma
  2. Atticoantral (Unsafe/Squamous) type - marginal/attic perforation, cholesteatoma present

Principles of Surgical Management: The goals are: eradicate disease, create a dry ear, prevent complications, and restore hearing.

I. Surgery for Tubotympanic CSOM
A. Myringoplasty (Type I Tympanoplasty)
  • Repair of TM perforation only, ossicular chain intact
  • Graft materials: temporalis fascia (most common), perichondrium, fat
  • Approaches: underlay (subepithelial) or overlay (epithelial)
  • Performed when ear is dry for 6+ weeks
  • Success rate: 85-90%
B. Tympanoplasty (Type I-V)
  • Wullstein's classification:
    • Type I: Myringoplasty only
    • Type II: Graft onto incus (when malleus absent)
    • Type III: Graft onto stapes head (columella effect)
    • Type IV: Graft over mobile stapes footplate
    • Type V: Fenestration of horizontal semicircular canal
C. Ossiculoplasty: Reconstruction of ossicular chain using autograft (incus), homograft, or PORP/TORP (partial/total ossicular replacement prosthesis).

II. Surgery for Atticoantral CSOM (Cholesteatoma)
A. Mastoidectomy Types:
1. Cortical (Simple) Mastoidectomy
  • Removes mastoid air cells while preserving posterior canal wall
  • Used for acute mastoiditis, acute coalescent mastoiditis
  • All three surgical canals (mastoid antrum, aditus, posterior wall of EAC) left intact
2. Modified Radical Mastoidectomy (MRM)
  • Removes posterior meatal wall, externalizes mastoid cavity
  • Attic, antrum and mastoid exenterated
  • Middle ear partially preserved (ossicles and TM remnant)
  • Canal wall down procedure
  • Best for contained/limited atticoantral disease
  • Hearing better preserved than in radical
3. Radical Mastoidectomy
  • Complete removal of middle ear contents + mastoid
  • Entire canal wall removed
  • Creates a large open cavity (mastoid bowl)
  • Eustachian tube orifice obliterated
  • Reserved for extensive disease, malignancy, or failed previous surgery
  • Results in maximum conductive hearing loss (50-60 dB)
4. Canal Wall Up (Intact Canal Wall) Mastoidectomy
  • Posterior tympanotomy approach
  • Preserves posterior meatal wall
  • Better hearing outcomes, lower cavity problems
  • Higher recurrence/residual cholesteatoma risk (10-20%)
  • Requires second-look surgery at 12 months
5. Atticotomy / Epitympanotomy
  • Limited surgery for attic cholesteatoma
  • Removal of lateral attic wall
  • Can be combined with tympanoplasty

III. Mastoid Obliteration
  • Used after canal wall down surgery
  • Obliterates the mastoid bowl using: abdominal fat, temporalis muscle flap, bone pate
  • Reduces cavity size, decreases cleaning requirements

IV. Combined Approach Tympanoplasty (CAT)
  • Introduced by Jansen
  • Stage 1: Cortical mastoidectomy + tympanoplasty
  • Stage 2 (12 months later): Second-look, reconstruct ossicles
  • Best hearing results with lowest recurrence

V. Complications of Surgery:
  • Facial nerve palsy
  • Sensorineural hearing loss
  • Labyrinthitis / perilymph fistula
  • CSF leak / meningitis
  • Persistent cavity problems (wet mastoid bowl)
  • Recurrent/residual cholesteatoma

Post-operative Care:
  • Ear dry for 6 weeks
  • Ear drops (antibiotic + steroid)
  • Regular aural toilet
  • Audiological review
  • Cavity cleaning (for open cavity procedures)


SHORT ESSAYS (5 Marks each)


Q2. Acute & Chronic Rhinosinusitis and Their Complications

Definitions:
  • Acute: Symptoms <12 weeks with complete resolution
  • Chronic: Symptoms >12 weeks without complete resolution; may have acute exacerbations
Rhinosinusitis: Inflammation of mucosa of nose and one or more paranasal sinuses (PNS).
Classification (EPOS):
  • Acute (<12 weeks): viral (common cold <10 days), post-viral (>10 days improvement then worsen), bacterial
  • Chronic (>12 weeks): with or without nasal polyps
Acute Rhinosinusitis - Features:
  • Nasal obstruction, mucopurulent discharge (anterior/posterior)
  • Facial pain/pressure (worse on bending)
  • Reduction of smell, fever
  • Maxillary most commonly involved
Causative organisms (acute bacterial): Streptococcus pneumoniae, H. influenzae, Moraxella catarrhalis
Chronic Rhinosinusitis - Features:
  • Nasal blockage, nasal discharge
  • Facial pain (mild/pressure), hyposmia
  • 2 or more symptoms >12 weeks
  • Confirmed by: nasal endoscopy, CT PNS
Management:
  • Acute: saline irrigation, intranasal steroids, analgesics; antibiotics (amoxicillin) if bacterial
  • Chronic: topical steroids (mainstay), saline irrigation, oral steroids (short course), long-term macrolides; surgery (FESS) for refractory cases

Complications of Rhinosinusitis:
Orbital Complications (most common - ethmoid sinus): Chandler's Classification:
  1. Preseptal (periorbital) cellulitis - anterior to orbital septum
  2. Orbital cellulitis - posterior to orbital septum
  3. Subperiosteal abscess - between periorbita and orbital wall
  4. Orbital abscess - within orbit
  5. Cavernous sinus thrombosis - most severe, bilateral proptosis
Intracranial Complications:
  • Meningitis (most common intracranial complication)
  • Extradural abscess
  • Subdural empyema
  • Brain abscess (frontal lobe - from frontal sinusitis)
  • Cavernous sinus thrombosis
  • Superior sagittal sinus thrombosis
Bony Complications:
  • Osteomyelitis of frontal bone = Pott's puffy tumor (fluctuant forehead swelling)
  • Orbital roof erosion
Mucocele / Mucopyocele: Accumulation of mucus expanding sinus (usually frontal or ethmoid) - causes bony expansion, proptosis

Q3. Congenital Lesions of the Larynx

Introduction: Present at birth; may cause stridor, respiratory distress, dysphagia.
Classification:
1. Laryngomalacia (Most common - 75% of all congenital stridor)
  • Immature, omega-shaped epiglottis + short aryepiglottic folds
  • Inspiratory stridor, worse when supine, crying, feeding
  • "Crowing" sound
  • Usually self-resolving by 12-18 months
  • Surgery: supraglottoplasty for severe cases (failure to thrive, apnea)
2. Vocal Cord Paralysis (2nd most common)
  • Unilateral: hoarse cry, aspiration (often due to birth trauma, cardiovascular anomalies)
  • Bilateral: respiratory distress, stridor (more dangerous); causes include CNS lesions (Arnold-Chiari), birth trauma
  • Management: unilateral - observe; bilateral - may need tracheostomy; thyroplasty later
3. Subglottic Stenosis (SGS)
  • Congenital or acquired (post-intubation)
  • Congenital: incomplete canalization; normal cricoid ring <4mm in term neonate
  • Biphasic stridor
  • Classified by Myer-Cotton grading (I-IV)
  • Treatment: balloon dilation, laryngotracheal reconstruction (LTR), cricotracheal resection
4. Laryngeal Webs
  • Failure of recanalization (6th-10th week of fetal life)
  • Mostly anterior (75%)
  • Thin web: dysphonia, mild stridor
  • Thick web: respiratory distress
  • Cohen classification: Grade I-IV
  • Treatment: endoscopic division (thin), keel insertion, laryngotracheal reconstruction
5. Subglottic Hemangioma
  • Presents 2-3 months of life (as hemangioma enlarges)
  • Biphasic stridor, 50% have skin hemangiomas
  • "Asymmetric subglottic narrowing" on X-ray
  • Treatment: propranolol (first-line), CO2 laser, steroids, tracheostomy if severe
6. Laryngeal Atresia / Aplasia
  • Rare, incompatible with life unless immediately managed with tracheostomy
7. Posterior Laryngeal Cleft
  • Incomplete fusion of posterior cricoid lamina
  • Ranges from small interarytenoid cleft to total laryngotracheoesophageal cleft
  • Presents with aspiration, recurrent pneumonia, choking
  • Diagnosed by direct laryngoscopy
  • Treatment: endoscopic repair (Type I/II), open surgery (Type III/IV)
8. Bifid Epiglottis
  • Rare, associated with Pallister-Hall syndrome
  • Usually asymptomatic

Q4. Otosclerosis

Definition: A disease of labyrinthine capsule (otic capsule) characterized by abnormal bone remodeling, where normal endochondral bone is replaced by spongy vascular bone (spongiosis).
Epidemiology:
  • Most common cause of progressive conductive hearing loss in young adults (15-45 yrs)
  • Female > Male (2:1)
  • Bilateral in 70-80% (one ear usually worse)
  • Autosomal dominant with incomplete penetrance (25-40%)
  • Whites > Blacks > Asians
Etiology: Genetic (multifactorial), measles virus (? role), fluoride deficiency, estrogen influence (worsens in pregnancy)
Pathology:
  • Fixation of stapes footplate at oval window (most common site = fissula ante fenestram)
  • Causes conductive hearing loss
  • If cochlear (cochlear otosclerosis): sensorineural hearing loss component
Clinical Features:
  • Insidious, progressive conductive hearing loss
  • Bilateral, usually asymmetric
  • Paracusis Willisii: hears better in noisy environments (due to others speaking louder)
  • Tinnitus (low frequency)
  • TM normal
  • Schwartze sign: flamingo pink blush seen through TM = active disease (hypervascular focus)
Audiological Findings:
  • Conductive hearing loss (low frequency first)
  • Carhart's notch: dip at 2000 Hz in bone conduction
  • Type As (stiffness) tympanogram - flat or reduced compliance
  • Absent stapedial reflexes
  • If cochlear: mixed or pure SNHL
Diagnosis: Clinical + audiometry; HRCT temporal bone (halo sign around cochlea, footplate thickening)
Treatment:
Medical:
  • Sodium fluoride: stabilizes otosclerosis (fluoride theory); 25 mg/day
  • Bisphosphonates
  • Not curative; slows progression
Surgical (Stapedectomy / Stapedotomy):
  • Stapedotomy (preferred): Small fenestra (0.6-0.8 mm) drilled in footplate; piston (Teflon/stainless steel) placed from incus to oval window
  • Stapedectomy: Total footplate removal + tissue graft + piston
  • Success: 90-95% closure of air-bone gap to <10 dB
  • Risks: dead ear (1%), SNHL (1-2%), perilymph fistula, tinnitus, taste disturbance (chorda tympani)
  • Contraindications: only hearing ear, active infection, endolymphatic hydrops
Hearing Aid: For bilateral disease, poor surgical candidate, cochlear otosclerosis component

Q5. Deviated Nasal Septum (DNS)

Definition: Displacement of the nasal septum from the midline, resulting in unequal nasal passages.
Anatomy: Septum composed of: perpendicular plate of ethmoid (upper), vomer (lower posterior), quadrilateral cartilage (anterior), nasal crest of maxilla and palatine bone.
Etiology:
  • Birth trauma (most common cause in neonates)
  • Developmental (unequal growth of septal components during puberty)
  • Trauma (fractures)
  • Intrinsic growth disturbances (Killian's theory)
Types of Deviation:
  1. C-shaped (simple curvature to one side)
  2. S-shaped (bilateral involvement)
  3. Dislocation from groove of vomer/maxillary crest
  4. Deviation with spur (bony projection at junction of bone and cartilage)
  5. Thickening or ridge
  6. Combination
Clinical Features:
  • Nasal obstruction (unilateral or bilateral; may alternate due to nasal cycle)
  • Compensatory hypertrophy of inferior turbinate on opposite side
  • Headache (spur pressing on turbinate = contact headache / Sluder's neuralgia)
  • Epistaxis (due to dryness at spur / deviation)
  • Sinusitis (due to ostial blockage)
  • Anosmia/hyposmia
  • Snoring and sleep apnea
Examination: Anterior rhinoscopy: deflection, spur, ridge; Nasal endoscopy; CT PNS for pre-surgical planning
Medical Management: Topical decongestants, saline irrigation, intranasal steroids (for associated mucosal inflammation)
Surgical Management:
1. Septoplasty (SMR = Submucous Resection - Killian's operation):
  • Incision: hemitransfixion or Killian's incision
  • Mucoperichondrial flaps elevated
  • Deviated cartilage/bone removed or repositioned
  • Mucosal flaps replaced
  • Advantage over SMR: preserves cartilage (maintains support)
2. Submucous Resection (SMR - older technique):
  • More cartilage removed; may cause saddle nose deformity
  • Replaced largely by septoplasty
3. Septorhinoplasty: When external cosmetic deformity also present
Complications of Surgery:
  • Septal hematoma/abscess
  • Septal perforation
  • Saddle nose deformity (loss of dorsal support)
  • Epistaxis
  • Anosmia
  • Synechiae (adhesions)
  • CSF rhinorrhea (rare)
Post-op: Nasal packing for 24-48 hours; saline douching; splint if rhinoplasty done

Q6. Acoustic Neuroma and Its Management

Definition: Benign, slow-growing tumor arising from Schwann cells of the vestibular portion (most often superior vestibular nerve) of CN VIII. Also called vestibular schwannoma.
Epidemiology:
  • Most common CPA (cerebellopontine angle) tumor (80-90% of CPA tumors)
  • Bilateral = Neurofibromatosis type 2 (NF2 - mutation on chromosome 22)
  • Peak age: 40-60 years; F slightly > M
  • Unilateral in 95% of cases
Pathology:
  • Antoni A tissue (compact, ordered Schwann cells) and Antoni B tissue (loose myxoid)
  • Verocay bodies (palisaded nuclei) in Antoni A areas
Clinical Features (depend on size):
  • Small tumor (intracanalicular): Unilateral SNHL (most common symptom), tinnitus (high frequency), mild disequilibrium
  • Medium tumor: Progressive SNHL, vestibular dysfunction, fullness in ear
  • Large tumor: Facial nerve involvement (late - because facial nerve is resistant), trigeminal symptoms (numbness/pain), cerebellar ataxia
  • Very large tumor: Raised ICP (hydrocephalus), brainstem compression, dysphagia
Investigations:
  • Pure Tone Audiometry: high-frequency SNHL; poor speech discrimination
  • ABR (Auditory Brainstem Response): increased interwave latency I-III and I-V; screening test
  • MRI with gadolinium (gold standard): enhancing lesion in IAC/CPA
  • CT: widening of IAC
Koos Classification (staging):
  • Grade I: intracanalicular
  • Grade II: in CPA but <2 cm, not touching brainstem
  • Grade III: touching brainstem
  • Grade IV: compressing brainstem
Management:
1. Watch and Wait (Observation):
  • Elderly, small tumor (<1.5 cm), poor health, single hearing ear
  • Annual MRI for 5 years, then biannual
  • ~40-50% show no growth over time
2. Surgical Resection: Three main approaches:
  • Translabyrinthine approach: Best for large tumors, no functional hearing; sacrifices hearing; best facial nerve visualization; no brain retraction
  • Middle cranial fossa approach: Small intracanalicular tumors with good hearing; hearing preservation possible
  • Retrosigmoid (suboccipital) approach: Any size; hearing preservation possible; risk of cerebellar retraction, headache
Aim: total tumor removal with facial nerve preservation (House-Brackmann scale used to grade facial function)
3. Stereotactic Radiosurgery (Gamma Knife / CyberKnife):
  • For small to medium tumors (<3 cm)
  • Elderly patients, poor surgical candidate
  • Hearing preservation better than surgery for small tumors
  • Local control rate: 90-95% at 10 years
  • Risks: temporary facial weakness, trigeminal numbness
Facial Nerve Monitoring: Intraoperative continuous EMG monitoring mandatory

Q7. Tumors of Nasopharynx - JNA (Juvenile Nasopharyngeal Angiofibroma)

Definition: JNA is a rare, benign but locally aggressive, highly vascular fibrous tumor arising from the posterolateral wall of the nasopharynx, specifically from the pterygopalatine fossa near the sphenopalatine foramen.
Epidemiology:
  • Almost exclusively in adolescent males (10-25 years)
  • "The bleed that must not be biopsied" - extreme vascularity causes massive hemorrhage on biopsy
  • Constitutes 0.05% of all head and neck tumors
Blood Supply: Internal maxillary artery (external carotid system) primarily; may also receive from internal carotid
Pathology:
  • Fibroblasts + thin-walled vascular spaces (no smooth muscle in vessel walls = cannot contract = bleeds profusely)
  • Unencapsulated
Clinical Features:
  • Massive, recurrent, spontaneous epistaxis (hallmark) - unilateral at first
  • Progressive nasal obstruction (unilateral)
  • Nasal discharge, anosmia
  • Conductive hearing loss (Eustachian tube obstruction)
  • Extension: cheek swelling (pterygopalatine fossa), proptosis (orbit), cranial nerve palsies, intracranial extension
Investigations:
  • CT with contrast: "Antral sign" - anterior bowing of posterior wall of maxillary sinus (pathognomonic)
  • MRI: "Salt and pepper" appearance (flow voids)
  • Angiography: highly vascular blush; used for pre-operative embolization
  • Holman-Miller sign on CT (anterior displacement of posterior maxillary sinus wall)
  • Do NOT biopsy in clinic
Staging - Andrews/Fisch/Session Classification:
  • Stage I: Nasopharynx/nasal cavity
  • Stage II: Paranasal sinuses, pterygopalatine fossa, orbit (without intracranial)
  • Stage III: Intracranial extradural
  • Stage IV: Intracranial intradural / cavernous sinus
Management:
Pre-operative embolization: 24-48 hours before surgery to reduce blood loss (blocks external carotid feeders)
Surgery (mainstay):
  • Endoscopic approach (preferred for Stage I/II): FESS-based endoscopic resection; lower morbidity, comparable recurrence
  • Open approaches:
    • Transpalatal (Rowe - for limited tumors)
    • Lateral rhinotomy + medial maxillectomy (moderate)
    • Infratemporal fossa approach (large Stage III)
    • Combined craniofacial (intracranial extension)
Radiotherapy: Used for intracranial or unresectable tumors; 30-36 Gy; risk of radiation-induced malignancy in young patients
Hormone therapy (testosterone blockade): Historically tried; not standard now
Recurrence: Up to 20%; due to incomplete resection; requires repeat surgery

Q8. Congenital Anomalies of Nose and PNS

Embryology: Nose develops from frontonasal process and nasal placodes (5th week). Choanae form when oronasal membrane ruptures (7th week). PNS develop as outgrowths of nasal cavity mucosa.
A. Congenital Anomalies of Nose:
1. Choanal Atresia (Most important)
  • Failure of oronasal membrane to rupture (7th week of fetal life)
  • Incidence: 1 in 7000-8000 births
  • F > M; Right side > Left side
  • Unilateral (50%): presents later with persistent unilateral discharge
  • Bilateral (50%): presents at birth with respiratory distress (newborns are obligate nasal breathers)
    • "Cyclic cyanosis": cyanosis relieved by crying (mouth breathing)
    • Fails to pass 6F catheter through nose
  • Associated anomalies: CHARGE syndrome (Coloboma, Heart defects, Atresia choanae, Retarded growth, Genital hypoplasia, Ear anomalies)
  • Types: bony (90%) + membranous (10%)
  • Diagnosis: CT scan (gold standard)
  • Treatment: bilateral = airway (McGovern nipple or oral airway), then surgical repair; transnasal endoscopic approach preferred; transpalatal (for thick bony atresia)
2. Pyriform Aperture Stenosis
  • Narrowing of bony pyriform aperture
  • Bilateral: neonatal respiratory distress
  • Associated with holoprosencephaly, single central maxillary incisor
  • CT confirms
3. Proboscis / Arhinia
  • Very rare; absent or rudimentary nose
  • Associated with brain anomalies
4. Nasal Dermoid
  • Pit or cyst on dorsum of nose
  • Can extend intracranially
  • Risk: pit with hair on dorsal nose = rule out intracranial extension with MRI before surgery
  • Treatment: surgical excision
5. Nasal Glioma
  • Heterotopic CNS tissue; no communication with CSF (unlike encephalocele)
  • Firm, non-compressible, non-pulsatile; does not enlarge with crying
  • 60% extranasal (over bridge of nose), 30% intranasal, 10% both
  • MRI to assess intracranial connection
  • Treatment: surgical excision
6. Nasal Encephalocele
  • Herniation of meninges ± brain tissue through skull defect
  • Compressible, pulsatile; enlarges on crying (Furstenburg test positive)
  • Transilluminates
  • MRI mandatory; DO NOT biopsy
  • Types: sincipital (frontoethmoidal), basal (through cribriform plate)
  • Treatment: neurosurgical repair (combined approach)
B. Congenital Anomalies of PNS:
1. Hypoplasia/Aplasia of sinuses
  • Maxillary sinus most commonly affected
  • Usually incidental finding
  • May predispose to sinusitis
2. Nasal Polyps in childhood
  • Always investigate for cystic fibrosis (bilateral polyps in child under 12 years)
  • Sweat test, genetic testing
3. Mucocele
  • Can be congenital due to obstruction of sinus ostium


SHORT ANSWERS (3 Marks each)


Q9. Nasal Polyposis

Definition: Multiple, bilateral, smooth, pale, gelatinous, non-tender, insensitive polyps arising from the ethmoidal sinuses (middle meatus), representing edematous protrusions of sinus mucosa.
Etiology/Associations:
  • Chronic rhinosinusitis (most common cause)
  • Allergy (atopy)
  • Aspirin sensitivity triad (Samter's triad): nasal polyps + aspirin sensitivity + bronchial asthma
  • Cystic fibrosis (in children - always screen)
  • Kartagener syndrome (immotile cilia)
Pathology: Edematous mucosa + eosinophilic infiltrate; goblet cell hyperplasia; basement membrane thickening
Clinical Features:
  • Bilateral nasal obstruction (characteristic)
  • Anosmia/hyposmia (olfactory polyps)
  • Rhinorrhea (watery/mucoid)
  • Snoring
  • Hyponasal voice
  • No pain (insensitive = cannot feel probe touch)
Appearance: Pale/grey, smooth, glistening, gelatinous, mobile (like "a peeled grape")
Investigations: Nasal endoscopy, CT PNS (staging), allergy testing, sweat test in children, biopsy to exclude malignancy/unilateral polyp
Staging (Meltzer): Based on CT findings (0-4)
Management:
  • Medical: Intranasal corticosteroids (mainstay - reduce size), short course oral steroids, saline irrigation, antihistamines (if allergic), aspirin desensitization (Samter's), biologics (dupilumab - for refractory CRS with polyps)
  • Surgical: FESS (Functional Endoscopic Sinus Surgery) - when medical treatment fails; removes polyps and opens sinus drainage pathways
  • High recurrence rate; lifelong topical steroid maintenance required

Q10. Fungal Sinusitis and Caldwell-Luc Operation

FUNGAL SINUSITIS:
Classification:
  1. Non-invasive:
    • Fungal ball (mycetoma): maxillary sinus most common; Aspergillus; unilateral; CT = hyperdense mass; treatment: FESS removal
    • Allergic Fungal Rhinosinusitis (AFRS): young atopics; Bipolaris/Curvularia; thick "peanut butter" mucin; bilateral; treatment: surgery + steroids
  2. Invasive:
    • Acute fulminant (rhinocerebral) mucormycosis: diabetics, immunocompromised; Mucor/Rhizopus; rapid destruction; black eschar; very high mortality; treatment: urgent surgical debridement + IV amphotericin B + control DM/immunosuppression
    • Chronic invasive: indolent, Sudan region; Aspergillus; treatment: surgical + antifungals
    • Granulomatous invasive: Sudan, immunocompetent; Aspergillus flavus; proptosis
Key Point for AFRS: "Allergic mucin" - eosinophilic mucin + sparse fungal hyphae on histology; elevated total IgE; positive skin prick test to fungi

CALDWELL-LUC OPERATION:
Definition: A surgical procedure to access the maxillary sinus through an incision in the gingivobuccal sulcus (sublabial incision) above the upper premolar/molar teeth.
Steps:
  1. Incision in the gingivobuccal sulcus (canine fossa)
  2. Elevation of mucoperiosteal flap
  3. Trephine through anterior wall of maxillary sinus (canine fossa)
  4. Complete removal of diseased mucosa
  5. Nasoantral window: counterdrainage through inferior meatus
  6. Wound closure
Indications:
  • Recurrent maxillary sinusitis not responding to FESS
  • Maxillary sinus foreign body
  • Maxillary sinus tumors (radical antrostomy)
  • Dental cysts involving sinus
  • Repair of CSF rhinorrhea
  • Orbital floor fractures (blowout fractures)
  • Fungal ball of maxillary sinus (when FESS fails)
  • Access for JNA resection
Complications:
  • Facial swelling/paresthesia (infraorbital nerve injury)
  • Dental numbness (injury to superior dental plexus)
  • Oro-antral fistula
  • Nasolacrimal duct injury
  • Mucocele formation (from retained mucosa)
  • Osteomyelitis
  • Cheek paresthesia (long-term)

Q11. Meniere's Disease

Definition: An idiopathic disorder of the inner ear characterized by episodic attacks of the triad: vertigo, sensorineural hearing loss (SNHL), and tinnitus (often with aural fullness).
Pathology: Endolymphatic hydrops (distension of endolymphatic compartment) - overproduction or reduced resorption of endolymph
Clinical Features (classic triad + fullness):
  • Episodic vertigo: rotatory, severe, lasts 20 min to 24 hours (key: NOT seconds, NOT days)
  • Fluctuating SNHL: low-frequency initially; progressive; worse during attacks
  • Tinnitus: low-pitched, roaring/rumbling; worse before/during attacks
  • Aural fullness/pressure: often precedes attack
Attacks recur; between attacks patient may be normal (early) or have persistent low-frequency SNHL (later)
Audiometry:
  • Low-frequency SNHL (classical early finding)
  • Recruitment present
  • Type C tympanogram (if severe)
  • Electrocochleography (EcochG): SP/AP ratio >0.4 (summating potential elevated)
  • VEMP (vestibular evoked myogenic potential): reduced amplitude
Diagnosis: American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) criteria:
  • Definite: 2+ spontaneous episodes vertigo >20 min + documented SNHL + tinnitus/aural fullness + no other cause
  • Probable: 2+ episodes dizziness + other criteria
Management:
Medical (first-line):
  • Salt restriction (<1.5 g/day), avoid caffeine, alcohol, stress
  • Diuretics: acetazolamide, hydrochlorothiazide + triamterene (reduces endolymph production)
  • Betahistine: improves microcirculation; 16 mg TID (most widely used)
  • Acute attack: vestibular sedatives (prochlorperazine, diazepam)
Intratympanic injections:
  • Intratympanic dexamethasone: hearing-preserving; reduces attack frequency
  • Intratympanic gentamicin: chemical labyrinthectomy; controls vertigo but risks SNHL; used for refractory cases
Surgical:
  • Endolymphatic sac decompression/shunt: hearing-preserving; modest benefit
  • Vestibular nerve section: hearing-preserving; highly effective for vertigo control
  • Labyrinthectomy: sacrifices hearing; reserved for non-serviceable hearing + intractable vertigo

Q12. Acute and Chronic Tonsillitis

ACUTE TONSILLITIS:
Definition: Acute inflammation of the palatine tonsils.
Etiology:
  • Viral (most common, 70-80%): adenovirus, EBV, rhinovirus
  • Bacterial: Group A beta-hemolytic Streptococcus (GABHS) = most important bacterial cause; also Staphylococcus, H. influenzae
Clinical Features:
  • Sore throat, odynophagia, dysphagia
  • Fever, malaise, headache
  • Earache (referred via Jacobson's nerve - IX)
  • Trismus (in peritonsillar involvement)
  • Enlarged, erythematous tonsils; exudate (follicular) or membrane
  • Cervical lymphadenopathy (jugulodigastric = tonsillar node)
Types:
  • Catarrhal: hyperemia only
  • Follicular: yellow spots on tonsillar surface (follicles)
  • Membranous: coalesced exudate (differentiate from diphtheria)
  • Ulcerative
Investigations: Throat swab culture, Rapid Strep test, Monospot (EBV), blood counts
Treatment:
  • Antibiotics: penicillin V 10 days (GABHS); amoxicillin (avoid if EBV - causes rash); erythromycin if penicillin-allergic
  • Analgesics/antipyretics, warm saline gargles, fluids
  • Do NOT give aspirin (Reye syndrome risk in children)
Complications: Peritonsillar abscess (quinsy), retropharyngeal abscess, parapharyngeal abscess, rheumatic fever, glomerulonephritis, otitis media, airway obstruction

CHRONIC TONSILLITIS:
Definition: Persistent tonsil infection with recurrent acute episodes or continuous low-grade infection.
Features:
  • Recurrent sore throats, mild dysphagia
  • Foul breath (halitosis) - from inspissated tonsillar debris
  • Caseous/cheesy material expressed from tonsillar crypts
  • Tonsils: enlarged or small/scarred (from repeated fibrosis)
  • Persistent cervical lymphadenopathy
Paradise Criteria for Tonsillectomy:
  • 7+ episodes in 1 year, OR
  • 5+ in each of 2 consecutive years, OR
  • 3+ in each of 3 consecutive years
  • Each episode must: have T>38.3°C, cervical lymphadenopathy, tonsillar exudate, positive GABHS culture
Tonsillectomy (surgical):
  • Indications: chronic tonsillitis (Paradise criteria), obstructive sleep apnea, peritonsillar abscess, suspected malignancy, asymmetric tonsils
  • Contraindications: acute infection (wait 3 weeks), bleeding disorders, cleft palate
  • Techniques: dissection and snare, coblation, bipolar diathermy, laser
  • Complications: primary hemorrhage (<24h - reactionary 6-24h), secondary hemorrhage (5-10 days post-op - most feared), pain, dehydration

Q13. Facial Nerve Anatomy and Its Diseases

ANATOMY:
Nuclear Origin: Pons - two nuclei:
  • Upper nucleus (bilateral cortical supply): upper face (forehead)
  • Lower nucleus (contralateral supply only): lower face
Course:
1. Intracranial segment: Pons to IAC; travels with CN VIII + nervus intermedius
2. Internal Auditory Canal (IAC) segment: 7-8 mm
3. Labyrinthine segment (shortest, narrowest - 4 mm): Geniculate ganglion (first genu); branches: Greater superficial petrosal nerve (GSPN - to lacrimal gland via pterygopalatine fossa), Deep petrosal nerve
4. Tympanic (horizontal) segment: Along medial wall of middle ear above oval window; 13 mm; vulnerable in middle ear surgery; second genu
5. Mastoid (vertical/descending) segment: 13 mm; branches: Nerve to stapedius, Chorda tympani (taste anterior 2/3 tongue, submandibular/sublingual glands)
6. Extratemporal segment (beyond stylomastoid foramen): Posterior auricular nerve, branch to digastric/stylohyoid, then parotid gland; divides at pes anserinus into:
  • Temporofacial division: temporal, zygomatic branches
  • Cervicofacial division: buccal, marginal mandibular, cervical branches
FNMG (Facial Nerve Monitoring): EMG-based; used in parotid surgery, skull base surgery, mastoid surgery

DISEASES OF FACIAL NERVE:
1. Bell's Palsy (Idiopathic/most common peripheral facial palsy):
  • Reactivation of HSV-1 in geniculate ganglion
  • Sudden unilateral complete LMN palsy (forehead involved)
  • House-Brackmann grading: I (normal) - VI (complete paralysis)
  • Treatment: prednisolone (60 mg/day, 5 days then taper) + acyclovir (controversial); eye care
  • Prognosis: 85% complete recovery without treatment
2. Ramsay Hunt Syndrome (Herpes Zoster Oticus):
  • VZV reactivation in geniculate ganglion
  • Triad: painful herpetic vesicles in EAC/pinna + ipsilateral LMN facial palsy + sensorineural hearing loss/tinnitus/vertigo
  • Treatment: acyclovir (800 mg 5x/day) + prednisolone; worse prognosis than Bell's
3. Acoustic Neuroma: Facial palsy is late (nerve is displaced, not compressed early)
4. Cholesteatoma: Erodes fallopian canal; facial palsy = cholesteatoma until proven otherwise
5. Temporal bone fractures:
  • Transverse fracture: higher incidence of facial palsy (50%); often passes through otic capsule
  • Longitudinal fracture: 20% facial palsy; most common type of temporal bone fracture (80%)
6. Parotid tumors/surgery: Extratemporal segment vulnerable
7. Central vs Peripheral palsy:
  • Upper motor neuron (central): forehead SPARED (bilateral cortical supply to upper nucleus)
  • Lower motor neuron (peripheral): forehead INVOLVED

Q14. Anatomy of Ear - External, Middle and Inner Ear

EXTERNAL EAR:
Pinna (Auricle):
  • Fibroelastic cartilage covered by skin (no cartilage in lobule)
  • Key landmarks: helix, antihelix, tragus, antitragus, concha, scapha, triangular fossa, lobule
  • Blood supply: superficial temporal artery (anterior), posterior auricular artery (posterior)
  • Nerve supply: auriculotemporal (V3), great auricular (C2/C3), lesser occipital, Arnold's nerve (vagal branch CN X - auricular branch: ear-cough reflex)
External Auditory Canal (EAC):
  • Length: 24 mm (1 inch); S-shaped
  • Outer 1/3: cartilaginous (contains hair, ceruminous glands, sebaceous glands); lined by stratified squamous epithelium
  • Inner 2/3: bony; thinner skin (no hairs/glands); isthmus = narrowest point
  • Blood supply: superficial temporal + posterior auricular + deep auricular (from maxillary)
  • Sensory nerve supply: CN V3, VII, IX, X
  • Fissures of Santorini (in cartilaginous EAC - infection can spread to parotid)
Tympanic Membrane:
  • Cone-shaped; 9 mm diameter; faces downward, outward, forward
  • Pars tensa (most): 3 layers - outer squamous, middle fibrous (radial + circular), inner mucosal
  • Pars flaccida (Shrapnell's membrane): superior, above malleolar folds; lacks fibrous layer
  • Handle of malleus: visible; umbo = tip; light reflex at 5 o'clock (right), 7 o'clock (left)
  • Blood supply: deep auricular artery (outer), anterior tympanic (inner)

MIDDLE EAR (Tympanic Cavity):
Six walls:
  • Roof (tegmental): tegmen tympani (thin bone)
  • Floor: jugular wall (jugular bulb)
  • Medial: labyrinthine wall - oval window, round window, promontory, lateral semicircular canal bulge
  • Lateral: tympanic membrane + scutum
  • Anterior: carotid wall (carotid canal), Eustachian tube, tensor tympani canal
  • Posterior: mastoid wall - aditus ad antrum, facial nerve, pyramidal eminence
Ossicles:
  • Malleus: handle (manubrium), neck, head; head = epitympanum
  • Incus: body, short process (posterior), long process (medial wall), lenticular process (articulates with stapes head)
  • Stapes: head, neck, anterior/posterior crura, footplate (oval window)
  • Two joints: incudomalleolar, incudostapedial (lenticular process + stapes head)
Muscles: Tensor tympani (tensor - medial pterygoid n. from V3), Stapedius (smallest skeletal muscle - facial nerve CN VII)
Eustachian Tube:
  • 35 mm long; cartilaginous (medial 2/3) + bony (lateral 1/3)
  • Angle: 45° adult, 10° child (horizontal - more prone to otitis media)

INNER EAR:
Bony labyrinth (contains perilymph):
  • Cochlea: 2.5 turns; scala vestibuli (perilymph) + scala tympani (perilymph); connected at helicotrema
  • Vestibule: utricle + saccule (otoliths/maculae - linear acceleration)
  • Semicircular canals (3): anterior, posterior, lateral; ampulla; cristae (angular acceleration)
Membranous labyrinth (contains endolymph - high K, low Na):
  • Cochlear duct (scala media): contains organ of Corti
  • Utricle and saccule: connected via utriculosaccular duct to endolymphatic duct/sac
  • Endolymphatic sac: in posterior fossa dura - resorbs endolymph
Organ of Corti:
  • Inner hair cells (3,500): primary sensory cells
  • Outer hair cells (12,000-15,000): amplification (prestin motor protein)
  • Supported by cells: Pillar cells, Deiters, Hensen, Claudius, Boettcher
  • Tonotopic organization: high frequency at base, low frequency at apex
  • Innervation: spiral ganglion (cell bodies) → cochlear nerve (CN VIII)
Blood supply: Internal auditory artery (from AICA) → common cochlear artery + anterior vestibular artery

Q15. Anatomy of Tonsil

Definition: The palatine tonsils are paired masses of lymphoid tissue located in the tonsillar fossa (between anterior and posterior pillars of fauces).
Location: Oropharynx, in the tonsillar fossa between:
  • Anterior pillar: palatoglossus muscle (glossopalatine arch)
  • Posterior pillar: palatopharyngeus muscle (pharyngopalatine arch)
Structure:
  • Covered by stratified squamous epithelium (continuous with oropharynx)
  • 10-20 tonsillar crypts (invaginations) - increase surface area for immune surveillance
  • Fibrous capsule (incomplete) separates tonsil from underlying pharyngeal muscles
  • Loose areolar tissue between capsule and superior constrictor = peritonsillar space (site of peritonsillar abscess)
Relations:
  • Medial: oropharyngeal isthmus (only surface not covered by capsule = intratonsillar cleft)
  • Lateral (deep): superior constrictor muscle; then: loose areolar tissue; buccopharyngeal fascia; parapharyngeal space; styloid process; facial vessels (external carotid, lingual artery); IX, X, XI, XII
  • Posterior: palatopharyngeus, pharyngeal wall
  • Superior: soft palate
  • Inferior: tongue base (posterior third)
Arterial Supply (5 arteries):
  1. Tonsillar artery (main) = branch of dorsal lingual artery (from lingual artery - external carotid)
  2. Ascending palatine artery (from facial artery)
  3. Descending palatine / greater palatine artery (from maxillary artery)
  4. Ascending pharyngeal artery
  5. Dorsal lingual artery
  • Most important vessel in tonsillectomy hemorrhage: external carotid artery lies lateral to tonsil
Venous Drainage: Peritonsillar plexus → pharyngeal plexus → internal jugular vein
Lymphatic Drainage: Upper deep cervical nodes (jugulodigastric node = "tonsillar node" - first to enlarge in tonsillitis)
Nerve Supply:
  • Glossopharyngeal nerve (CN IX - main) via tonsillar branches
  • Lesser palatine nerve (CN V2 via pterygopalatine ganglion)
  • Referred otalgia via CN IX → Jacobson's nerve → tympanic plexus
Function: Part of Waldeyer's ring (with adenoids/nasopharyngeal tonsil, tubal tonsils, lingual tonsil); B-cell and T-cell immune responses; IgA production; peaks size 4-10 years, involutes at puberty

Q16. Otostichosis / Otospongiosis

(Note: "Otostichosis" likely refers to otosclerosis/otospongiosis - a common alternate term in some curricula)
Definition: Otosclerosis (also called otospongiosis in its active phase) is a disease of the otic capsule characterized by disordered bone remodeling, where the normal dense enchondral bone of the labyrinthine capsule is replaced by abnormal spongy vascular bone. The active "otospongiosis" phase (with vascular spongy bone) progresses to the sclerotic "otosclerosis" phase (dense sclerotic bone causing fixation).
Key Points:
  • The term otospongiosis refers to the histological active phase: resorption + vascular spongy bone (sites appear as blue mantles = "blue mantles of Manasse" on H&E staining)
  • The term otosclerosis refers to the mature/sclerotic phase with bony fixation
  • Clinically the conditions are identical and the terms used interchangeably
Histology of Otospongiosis:
  • Active focus: rich vascular channels, osteoclast-mediated bone resorption, basophilic reversal lines
  • "Blue mantles of Manasse" = reversal lines visible on H&E
  • Inactive/sclerotic focus: dense lamellar bone, reduced vascularity
Differentiating Features from Standard Otosclerosis (clinical):
  • Schwartze sign: flamingo pink blush visible through TM = active otospongiosis (vascular focus)
  • CT temporal bone: halo sign (lucent halo around cochlea in cochlear otosclerosis/otospongiosis)
For full clinical features, investigations, and management, refer to Q4 (Otosclerosis) above.

If "Otostichosis" refers to a separate entity: Some texts use this term for calcification or adhesions in middle ear - but this is non-standard. The standard ENT examination term is otosclerosis/otospongiosis.
---Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.